Regulation of the Molecular Brake Region in FGFR2 Kinase

被引：0
|
作者：
Karp, Jerome M. [1 ]
Cowburn, David [1 ]
机构：
[1] Yeshiva Univ, Albert Einstein Coll Med, Biochem, Bronx, NY USA
来源：
BIOPHYSICAL JOURNAL | 2015年 / 108卷 / 02期
关键词：
D O I：
10.1016/j.bpj.2014.11.2907
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
2684-Pos
引用
收藏
页码：530A / 530A
页数：1
相关论文
共 50 条
  • [31] FGFR2 MUTATIONS IN PFEIFFER SYNDROME
    LAJEUNIE, E
    MA, HW
    BONAVENTURE, J
    MUNNICH, A
    LEMERRER, M
    RENIER, D
    NATURE GENETICS, 1995, 9 (02) : 108 - 108
  • [32] Polyclonal secondary FGFR2 mutations drive acquired resistance to FGFR inhibition in FGFR2 fusion-positive cholangiocarcinoma patients
    Goyal, Lipika
    Saha, Supriya K.
    Liu, Leah Y.
    Siravegna, Giulia
    Leshchiner, Ignaty
    Ahronian, Leanne G.
    Lennerz, Jochen K.
    Phuong Vu
    Mussolin, Benedetta
    Reyes, Stephanie
    Furet, Pascal
    Iafrate, A. John
    Getz, Gad
    Porta, Diana G.
    Tiedt, Ralph
    Bardelli, Alberto
    Juric, Dejan
    Corcoran, Ryan B.
    Bardeesy, Nabeel
    Zhu, Andrew X.
    CANCER RESEARCH, 2017, 77
  • [33] Inactivation of fgfr1 and fgfr2 in Postnatal Astrocytes
    Rubin, L. B.
    Smith, K.
    INTEGRATIVE AND COMPARATIVE BIOLOGY, 2017, 57 : E392 - E392
  • [34] Familial scaphocephaly syndrome caused by a novel mutation in the FGFR2 tyrosine kinase domain
    McGillivray, G
    Savarirayan, R
    Cox, TC
    Stojkoski, C
    McNeil, R
    Bankier, A
    Bateman, JF
    Roscioli, T
    Gardner, RJM
    Lamandé, SR
    JOURNAL OF MEDICAL GENETICS, 2005, 42 (08) : 656 - 662
  • [35] Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing
    Neumann, Olaf
    Burn, Timothy C.
    Allgaeuer, Michael
    Ball, Markus
    Kirchner, Martina
    Albrecht, Thomas
    Volckmar, Anna-Lena
    Beck, Susanne
    Endris, Volker
    Goldschmid, Hannah
    Lehmann, Ulrich
    Seker-Cin, Huriye
    Uhrig, Sebastian
    Roessler, Stephanie
    Budczies, Jan
    Froehling, Stefan
    Longerich, Thomas
    Wagner, Alex H.
    Vogel, Arndt
    Schirmacher, Peter
    Stenzinger, Albrecht
    Kazdal, Daniel
    BRITISH JOURNAL OF CANCER, 2022, 127 (08) : 1540 - 1549
  • [36] Incorporation of FGFR1 and FGFR2 amplification status determination in routine molecular prescreening for targeted therapies
    Prudkin, Ludmila
    Aura, Claudia
    Jimenez, Jose
    Peiro, Nerea
    Moreno, Debora
    Martinez, Paola
    Sanchez, Gertrudis
    Del Carmen Diaz, Maria
    Iglesias, Alejandra
    Angeles Diaz, Maria
    Vivancos, Ana
    Rodon, Jordi
    Cortes, Javier
    Oaknin, Ana
    Maria Del Campo, Jose
    Felip, Enriqueta
    Tabernero, Josep
    Nuciforo, Paolo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing
    Olaf Neumann
    Timothy C. Burn
    Michael Allgäuer
    Markus Ball
    Martina Kirchner
    Thomas Albrecht
    Anna-Lena Volckmar
    Susanne Beck
    Volker Endris
    Hannah Goldschmid
    Ulrich Lehmann
    Huriye Seker-Cin
    Sebastian Uhrig
    Stephanie Roessler
    Jan Budczies
    Stefan Fröhling
    Thomas Longerich
    Alex H. Wagner
    Arndt Vogel
    Peter Schirmacher
    Albrecht Stenzinger
    Daniel Kazdal
    British Journal of Cancer, 2022, 127 : 1540 - 1549
  • [38] Clinical impact of FGFR inhibitors on FGFR2 positive pancreatic cancer
    Stein, Leah
    Reeser, Julie W.
    Wing, Michele R.
    Murugesan, Karthikeyan
    Paruchuri, Anoosha
    Risch, Zachary
    Samorodnitsky, Eric
    Hoskins, Emily L.
    Smith, Amy
    Dao, Thuy
    Babcook, Melissa
    Imam, Muhammad
    Freud, Aharon
    Roychowdhury, Sameek
    CANCER RESEARCH, 2023, 83 (07)
  • [39] Lower FGFR2 mRNA Expression and Higher Levels of FGFR2 IIIc in HER2-Positive Breast Cancer
    Dix-Peek, Therese
    Dickens, Caroline
    Valcarcel, Juan
    Duarte, Raquel A. B.
    BIOLOGY-BASEL, 2024, 13 (11):
  • [40] Alofanib, a novel allosteric FGFR2 inhibitor, shows potent antitumor activity in ovarian cancer with FGFR2 expression
    Tjulandin, Sergei
    Byakhov, Mikhail
    Stepanova, Evgenia
    Khochenkov, Dmitry
    Harrison, Daniel
    Tsimafeyeu, Ilya
    CANCER RESEARCH, 2015, 75
12345